Radboudumc
Department of Radiology and Nuclear MedicineThe Department of
Radiology and Nuclear Medicine plays a leading role in intervention radiology.
Prof. Schultze Kool plays a leading role in the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN) and is a recognized expert in the multidisciplinary treatment of vascular malformations. In addition, he is setting up a European, multi-center registry on rare vascular malformation, following the FAIR principles.
Centre for Molecular and Biomolecular InformaticsThe
Centre for Molecular and Biomolecular Informatics (CMBI) develops bioinformatics approaches that contribute to the understanding of disease mechanisms, personalized therapies and interventions, and a learning health care system. The CMBI is committed to the reusability of their data, tools, and services, and puts the FAIR (Findable, Accessible, Interpretable, Reusable) data principles into action.
VASCERNIn March 2017, the European Commission launched 24 European Reference Networks for rare diseases (ERNs - European Reference Networks for rare diseases, video presentation
here). The aim is to facilitate and improve the care of rare disease patients in Europe by uniting European experts in order to share expertise, discuss complex clinical cases through telemedicine and teleexpertise, draft European clinical recommendations, launch new collaborative scientific research projects, develop training and education tools (eLearning), develop EU registries for rare diseases, disseminate knowledge and raise awareness. VASCERN is a 5-years project, which receives co-funding from the 3rd European Union Health Programme and from the EU Connecting Europe Facility (CEF) Programme for its eHealth technologies (ERN Core Services).
VASCERN has 30 Healthcare Providers (expert Centres / specialised units of European Hospitals) in 11 Member States of the European Union, and many patient organisations from all over Europe. The network will expand to new EU countries in the upcoming years. It is structured along 5 Rare Disease Working Groups, transversal working groups (eHealth/ Training & Education, Registry), and the European Patient Advocacy Group (ePAG) gathering patient advocates.
For more information see the websites below:
https://www.radboudumc.nl/en/people/peter-bram-t-hoenhttps://vascern.eu/RadboudumcRadboudumc strives to be a leading developer of sustainable, innovative and affordable healthcare to improve the health and wellbeing of people and society in the Netherlands and beyond. This is the core of our mission: To have a significant impact on healthcare. To get a better picture of what this entails, check out our
strategy.
Read more about what it means
to work at Radboudumc and how you can do your part.